Pelthos Therapeutics PTHS
NYSE PTHS
$20.30 -0.20 (-0.97%)
As of: Oct 21, 2026 · 11:41 AM EDT

Pelthos Therapeutics (PTHS) Non-Current Debt (2022 - 2026)

Updated

Pelthos Therapeutics' Non-Current Debt was $243.00 in Q4 2024.

Analysis

Pelthos Therapeutics (PTHS) Non-Current Debt (2022 - 2026) Analysis & Trends

For FY2024, Non-Current Debt at Pelthos Therapeutics came in at -$214,757.

  • In earlier years, Non-Current Debt was $300,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 62.48 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 60.50 Bn
10 Pelthos Therapeutics 70.79 Mn -17.60 Mn 11.99 Mn 26.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.59 Mn
Mar 31, 2026 26.36 Mn
Jun 30, 2025 131,868.00
Mar 31, 2025 131,868.00
Dec 31, 2024 132,000.00
Sep 30, 2024 131,868.00
Jun 30, 2024 131,868.00
Dec 31, 2023 750,082.00
Dec 31, 2022 104,800.00
API Access

Pelthos Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PTHS&period=max&api_key=YOUR_API_KEY